Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

With Dr. Lal PathLabs Limited's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 44.630116
debtToEquity 7.135000
earningsGrowth 0.242000
revenueGrowth 0.113000
grossMargins 0.579930
operatingMargins 0.235440
trailingEps 61.330000
forwardEps 29.380000

Dr. Lal PathLabs Limited's positive earnings and revenue growth suggest the company is on a path to business expansion. This upward trend signals strong financial health, indicating that Dr. Lal PathLabs Limited is well-positioned for sustained growth in both profits and revenue.
With positive gross and operating margins, Dr. Lal PathLabs Limited's profitability is evident. These metrics suggest the company is efficiently managing its expenses while maintaining strong revenue, highlighting a solid financial foundation.
LALPATHLAB's forward EPS is lower than its trailing EPS, indicating that the company is expected to be less profitable this year. This suggests a potential slowdown in financial performance.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

LALPATHLAB's price projections have been consistently revised upward, suggesting that analysts are becoming increasingly optimistic about the company's future. This trend reflects confidence in LALPATHLAB's ability to achieve strong financial results.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


51 Dr. Lal PathLabs Limited stock sales were completed, with market price of 3071.9274423636643.During the period under consideration, no sell transactions took place.More buys than sells near the current price levels of LALPATHLAB might signal a favorable outlook for the stock. Investors seem to be showing confidence by purchasing more, potentially expecting positive future performance.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Dr. Lal PathLabs Limited has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view Dr. Lal PathLabs Limited as a stable option to park their money and potentially benefit from the company's continued growth and profitability.